相关实验视频

Updated: Sep 14, 2025

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound

Published on: March 21, 2025

主要评分作为中等风险前列腺癌的预测标记:PSMA PET/CT成像的见解

Laura Evangelista^1,2, Lorenzo Muraglia², Priscilla Guglielmo^1,3

¹Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.

Nuclear medicine and molecular imaging

|July 21, 2025

概括

前列腺特异性膜抗原 (PSMA) PET/CT的PRIMARY评分可以预测中等风险前列腺癌 (PCa) 的格里森评分变化. 这种成像指标有助于评估疾病病理和预后,以更好地管理患者.

科学领域:

在瘤学瘤学.
放射学放射学是一门学科.
核医学就是核医学.

背景情况:

中期风险前列腺癌 (PCa) 需要准确的分期来指导治疗决策.
前列腺特异性膜抗原 (PSMA) 定子发射断层扫描/计算机断层扫描 (PET/CT) 是一种先进的成像技术,用于评估PCa.
对不良病理和预后的预测标记对于优化患者的治疗结果至关重要.

研究的目的:

评估来自PSMA PET/CT的PRIMARY评分对中等风险PCa的不良病理和预后的预测能力.
评估PRIMARY分数与格里森分数变化之间的相关性.
确定PRIMARY得分在预测生化复发中的有用性.

主要方法:

对78名中等风险的PCa患者进行了回顾性多中心分析.
使用多参数磁共振成像 (mpMRI) 和PSMA PET/CT ([68Ga]Ga-PSMA-11或[18F]F-PSMA1007) 进行的分期.
使用PI-RADS v2.1对MPMRI和PSMA PET/CT的PRIMARY得分进行定量分析.

主要成果:

在62%的有利风险病例和71%的不利风险病例中观察到>3的初级分数.
格里森得分的变化发生在20%的有利风险患者中,其中90%的Primary得分>3.3.
生物化学复发 (PSA>0.2 ng/ml) 在17%的患者中被观察到,主要是有利的风险病例,格里森评分变化和PRIMARY评分>3.3.

结论:

主要得分显示了格里森得分变化中等风险PCa的显著预测价值.
PSMA PET/CT PRIMARY评分可以帮助识别患有不良病理风险较高的患者.
这种成像指标可能有助于完善PCa的预后评估和治疗策略.

关键词:

生物化学复发的发生.中间风险是中间风险.聚乙烯/聚乙烯/聚乙烯在PSMA上,PSMA可以在PSMA上进行交易.前列腺癌是什么意思前列腺癌是什么意思

更多相关视频

Use of MRI-ultrasound Fusion to Achieve Targeted Prostate Biopsy

Use of MRI-ultrasound Fusion to Achieve Targeted Prostate Biopsy

Published on: April 9, 2019

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

Published on: April 24, 2020

相关概念视频

Positron Emission Tomography

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...